These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 1228748)

  • 1. [Hyperaldosteronism in thyrotoxicosis].
    Bezverkhaia TP
    Probl Endokrinol (Mosk); 1975; 21(5):26-9. PubMed ID: 1228748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Regulation of aldosterone secretion in patients with thyrotoxicosis. I. Role of the renin-angiotensin system and corticotropin in the development of secondary hyperaldosteronism in patients with thyrotoxicosis].
    Rybina LV; Natarov VV; Rom-Bugoslavskaia ES
    Probl Endokrinol (Mosk); 1983; 29(2):24-30. PubMed ID: 6304681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary hyperaldosteronism without suppressed renin due to secondary hypertensive kidney damage.
    Oelkers W; Diederich S; Bähr V
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3266-70. PubMed ID: 10999820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [State of the renin-angiotensin system in thyrotoxicosis].
    Koev D
    Probl Endokrinol (Mosk); 1975; 21(3):16-21. PubMed ID: 49892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mineralocorticoid function of the adrenal cortex in adolescent girls with thyrotoxicosis].
    Zhurova MV; Natarov VV; Rybina LV
    Probl Endokrinol (Mosk); 1978; 24(1):25-8. PubMed ID: 634943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long term evolution of glucocorticoid-suppressible hyperaldosteronism.
    Stockigt JR; Scoggins BA
    J Clin Endocrinol Metab; 1987 Jan; 64(1):22-6. PubMed ID: 3536983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 19-nor-deoxycorticosterone excretion in primary aldosteronism and low renin hypertension.
    Griffing GT; Dale SL; Holbrook MM; Melby JC
    J Clin Endocrinol Metab; 1983 Feb; 56(2):218-21. PubMed ID: 6337172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indicators of mineralocorticoid excess in the evaluation of primary aldosteronism.
    Balaş M; Zosin I; Maser-Gluth C; Hermsen D; Cupisti K; Schott M; Schinner S; Knoefel WT; Scherbaum WA; Willenberg HS
    Hypertens Res; 2010 Aug; 33(8):850-6. PubMed ID: 20520614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mineralocorticoid function of the adrenal cortex in thyrotoxicosis].
    Rom-Bugoslavskaia ES; Rybina LV; Komarova IV
    Vrach Delo; 1983 Oct; (10):81-4. PubMed ID: 6359705
    [No Abstract]   [Full Text] [Related]  

  • 11. [Malignant adrenal cortex carcinoma revealed by an isolated picture of primary hyperaldosteronism].
    Farge D; Pagny JY; Chatellier G; Plouin PF; Corvol P
    Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():83-7. PubMed ID: 3142435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased adrenal sensitivity to angiotensin II in idiopathic hyperaldosteronism.
    Wisgerhof M; Carpenter PC; Brown RD
    J Clin Endocrinol Metab; 1978 Nov; 47(5):938-43. PubMed ID: 400738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of captopril on aldosterone response to potassium infusion in primary aldosteronism.
    Fallo F; Chouman M; Pagotto U; Pistorello M
    Miner Electrolyte Metab; 1991; 17(3):185-9. PubMed ID: 1779941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the pathogenesis of Bartter's syndrome: report of studies in a patient with this disorder.
    Norby L; Mark AL; Kaloyanides GJ
    Clin Nephrol; 1976 Sep; 6(3):404-13. PubMed ID: 991467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical, biochemical and genetic approaches to the detection of familial hyperaldosteronism type I.
    Stowasser M; Bachmann AW; Jonsson JR; Tunny TJ; Klemm SA; Gordon RD
    J Hypertens; 1995 Dec; 13(12 Pt 2):1610-3. PubMed ID: 8903619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Primary hyperaldosteronism--12 clinical cases].
    Telles EC; Machado FS; da Silva EP; Lutucuta S; Almeida G; Coucelo J; Vagueiro C
    Rev Port Cardiol; 1999 Sep; 18(9):801-12. PubMed ID: 10536470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Rectal electrical potential difference and plasma aldosterone in hyperaldosteronism and low-, normal- and high-renin hypertension].
    Skrabal F; Mauser R
    Wien Klin Wochenschr; 1976 Dec; 88(23):777-81. PubMed ID: 1014711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plasma renin activity and plasma aldosterone during anaesthesia and operative stress and beta-adrenergic blockade (author's transl)].
    Wernze H; Hilfenhaus M; Rietbrock I; Schüttke R; Kühn K
    Anaesthesist; 1975 Nov; 24(11):471-6. PubMed ID: 2027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe hypertension in a ten-year-old boy secondary to an aldosterone-producing tumour identified by adrenal sonography.
    Decsi T; Soltész G; Harangi F; Nemes J; Szabó M; Pintér A
    Acta Paediatr Hung; 1986; 27(3):233-8. PubMed ID: 3535837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe hyperaldosteronism in neonatal Task3 potassium channel knockout mice is associated with activation of the intraadrenal renin-angiotensin system.
    Bandulik S; Tauber P; Penton D; Schweda F; Tegtmeier I; Sterner C; Lalli E; Lesage F; Hartmann M; Barhanin J; Warth R
    Endocrinology; 2013 Aug; 154(8):2712-22. PubMed ID: 23698720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.